Alvotech Soars 13% on FDA Nod That “Effectively Doubles” US Humira Biosimilar Capacity

Key TakeawaysAlvotech shares rose 13% after the FDA approved a second Reykjavik production suite for Simlandi, its Humira biosimilar, doubling the capacity available for U. S.